Literature DB >> 14666398

A high affinity ligand for GABAA-receptor containing alpha5 subunit antagonizes ethanol's neurobehavioral effects in Long-Evans rats.

Peter F McKay1, Katrina L Foster, Dynesha Mason, Rancia Cummings, Marin Garcia, La Shone Williams, Collette Grey, Shannan McCane, Xiaohui He, James M Cook, Harry L June.   

Abstract

RATIONALE: Previously, we reported that the GABA(A)receptor containing alpha(5)subunit played a significant role in the reinforcing actions of EtOH in rats selectively bred to consume alcohol. However, the role of the alpha(5) receptor in regulating the neurobehavioral effects of EtOH in outbred rats is not known.
OBJECTIVE: In the present study, RY024, a novel benzodiazepine (BDZ) inverse agonist with high affinity (K(d) approximately 0.40 nM) and selectivity (approximately 67.3-fold) for the alpha(5)receptor, was investigated for its capacity to antagonize EtOH's reinforcing, motor impairing, and sedative effects in Long-Evans rats.
METHODS: Rats were trained to lever press for EtOH under a fixed-ratio 1 schedule of reinforcement. Subsequent studies evaluated EtOH's motor-impairing effects in an oscillating bar task, while EtOH's sedative effects were measured in the open field.
RESULTS: RY024 (0.125-3.5 mg/kg; IP) markedly reduced EtOH-maintained responding with no effects on water responding, except for the highest dose. RY024 (3.0-15 mg/kg; IP) also reversed the motor impairing effects of a moderate (0.75 g/kg), and intoxicating EtOH dose (1.25 g/kg) in the absence of intrinsic effects. Finally, RY024 (7.5 mg/kg) attenuated the sedation produced by the 1.25 g/kg EtOH dose; however, it failed to attenuate the sedation induced by the 0.75 g/kg EtOH dose. Given alone, RY024 exhibited intrinsic effects in the open field.
CONCLUSION: The results suggest the GABA(A)receptor containing alpha(5)subtype plays an important role in regulating the reinforcing, motor-impairing, and sedative effects of alcohol in outbred rats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666398     DOI: 10.1007/s00213-003-1671-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

Review 1.  International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.

Authors:  E A Barnard; P Skolnick; R W Olsen; H Mohler; W Sieghart; G Biggio; C Braestrup; A N Bateson; S Z Langer
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

2.  Benzodiazepine receptor antagonists modulate the actions of ethanol in alcohol-preferring and -nonpreferring rats.

Authors:  H L June; S L Devaraju; M W Eggers; J A Williams; C R Cason; T L Greene; T Leveige; M R Braun; L Torres; J M Murphy
Journal:  Eur J Pharmacol       Date:  1998-01-26       Impact factor: 4.432

3.  GABA(A) receptors containing (alpha)5 subunits in the CA1 and CA3 hippocampal fields regulate ethanol-motivated behaviors: an extended ethanol reward circuitry.

Authors:  H L June; S C Harvey; K L Foster; P F McKay; R Cummings; M Garcia; D Mason; C Grey; S McCane; L S Williams; T B Johnson; X He; S Rock; J M Cook
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

4.  Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.

Authors:  U Rudolph; F Crestani; D Benke; I Brünig; J A Benson; J M Fritschy; J R Martin; H Bluethmann; H Möhler
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

5.  Responsivity and development of tolerance to the motor impairing effects of moderate doses of ethanol in alcohol-preferring (P) and -nonpreferring (NP) rat lines.

Authors:  R L Bell; R B Stewart; J E Woods ; L Lumeng; T K Li; J M Murphy ; W J McBride
Journal:  Alcohol Clin Exp Res       Date:  2001-05       Impact factor: 3.455

Review 6.  Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents.

Authors:  W J McBride; T K Li
Journal:  Crit Rev Neurobiol       Date:  1998

7.  The novel benzodiazepine inverse agonist RO19-4603 antagonizes ethanol motivated behaviors: neuropharmacological studies.

Authors:  H L June; L Torres; C R Cason; B H Hwang; M R Braun; J M Murphy
Journal:  Brain Res       Date:  1998-02-16       Impact factor: 3.252

8.  Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.

Authors:  K A Wafford; C J Bain; P J Whiting; J A Kemp
Journal:  Mol Pharmacol       Date:  1993-08       Impact factor: 4.436

9.  Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors.

Authors:  R Liu; R J Hu; P Zhang; P Skolnick; J M Cook
Journal:  J Med Chem       Date:  1996-04-26       Impact factor: 7.446

10.  Preclinical models to evaluate potential pharmacotherapeutic agents in treating alcoholism and studying the neuropharmacological bases of ethanol-seeking behaviors in rats.

Authors:  Harry L June
Journal:  Curr Protoc Neurosci       Date:  2002-08
View more
  16 in total

Review 1.  Low dose acute alcohol effects on GABA A receptor subtypes.

Authors:  Martin Wallner; H Jacob Hanchar; Richard W Olsen
Journal:  Pharmacol Ther       Date:  2006-07-11       Impact factor: 12.310

2.  α5GABAA subunit-containing receptors and sweetened alcohol cue-induced reinstatement and active sweetened alcohol self-administration in male rats.

Authors:  Cassie M Chandler; Jaren Reeves-Darby; Sherman A Jones; J Abigail McDonald; Guanguan Li; Md T Rahman; James M Cook; Donna M Platt
Journal:  Psychopharmacology (Berl)       Date:  2019-01-12       Impact factor: 4.530

3.  Chronic ethanol potentiates the effect of neuropeptide s in the basolateral amygdala and shows increased anxiolytic and anti-depressive effects.

Authors:  Johan Enquist; Madeline Ferwerda; Anuradha Madhavan; Derek Hok; Jennifer L Whistler
Journal:  Neuropsychopharmacology       Date:  2012-06-27       Impact factor: 7.853

4.  Alcohol selectivity of β3-containing GABAA receptors: evidence for a unique extracellular alcohol/imidazobenzodiazepine Ro15-4513 binding site at the α+β- subunit interface in αβ3δ GABAA receptors.

Authors:  M Wallner; H J Hanchar; R W Olsen
Journal:  Neurochem Res       Date:  2014-02-06       Impact factor: 3.996

Review 5.  Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity.

Authors:  Scott J Moeller; Edythe D London; Georg Northoff
Journal:  Neurosci Biobehav Rev       Date:  2015-12-01       Impact factor: 8.989

Review 6.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

7.  Sex Differences in the Expression of the α5 Subunit of the GABAA Receptor in Alcoholics with and without Cirrhosis of the Liver.

Authors:  Paulina Janeczek; Natalie Colson; Peter R Dodd; Joanne M Lewohl
Journal:  Alcohol Clin Exp Res       Date:  2020-01-09       Impact factor: 3.455

8.  GABAA receptor regulation of voluntary ethanol drinking requires PKCepsilon.

Authors:  Joyce Besheer; Veronique Lepoutre; Beth Mole; Clyde W Hodge
Journal:  Synapse       Date:  2006-11       Impact factor: 2.562

9.  Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to alpha4/6beta3delta GABAA receptors.

Authors:  H Jacob Hanchar; Panida Chutsrinopkun; Pratap Meera; Porntip Supavilai; Werner Sieghart; Martin Wallner; Richard W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

Review 10.  Physiology and pharmacology of alcohol: the imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development?

Authors:  M Wallner; R W Olsen
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.